Medtronic, Inc. Anticipates “Practice-Changing” Clinical Data for Interventional Cardiologists at EuroPCR

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT), today announced plans for the release of new clinical data on the Endeavor® Zotarolimus-Eluting Coronary Stent System and the Export® Aspiration Catheter at EuroPCR in Barcelona this week, May 13–16.